TMEM119 and neoplasm: Whereas FACS analysis concerned the tumor and the surrounding brain parenchyma, the observation is further supported by immunolabeling of intra-tumoral CD11c-EYFP+/TMEM119+/Iba1+ cells at day 28 (Fig. 5c, Additional file 3: Figure S3A).